|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0008976,
umls-concept:C0205263,
umls-concept:C0205265,
umls-concept:C0728940,
umls-concept:C1184482,
umls-concept:C1274040,
umls-concept:C1282910,
umls-concept:C1519429,
umls-concept:C1555582,
umls-concept:C1559154
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-3-12
|
|
pubmed:abstractText |
The rate of complete resection (50%) and the 5-year survival (30%) for non-small cell lung carcinomas of the superior sulcus have not changed for 40 years. Recently, combined modality therapy has improved outcome in other subsets of locally advanced non-small cell lung carcinoma. This trial tested the feasibility of induction chemoradiation and surgical resection in non-small cell lung carcinoma of the superior sulcus with the ultimate aim of improving resectability and survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0022-5223
|
|
pubmed:author |
pubmed-author:BurkesRR,
pubmed-author:CrowleyJJ,
pubmed-author:DeschampsCC,
pubmed-author:DetterbeckFF,
pubmed-author:GandaraDD,
pubmed-author:GirouxD JDJ,
pubmed-author:GoldbergMM,
pubmed-author:HazukaMM,
pubmed-author:JohnsonDD,
pubmed-author:KrautM JMJ,
pubmed-author:LivingstonRR,
pubmed-author:RuschV WVW,
pubmed-author:ShepherdFF,
pubmed-author:WintonTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
121
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
472-83
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
|
|
pubmed:affiliation |
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
